1000 Companies to Inspire Europe
In 2017, the London Stock Exchange Group (LSEG) listed us as one of 1000 Companies to Inspire Europe and included us in its annual report on “most dynamic and fast-growing” medium-sized companies in Europe.
To be included in the LSEG report companies must:
- demonstrate an outstanding compounded annual growth rate (CAGR) calculated over a three-year period (in this case for the years 2013–2015)
- most outperform their competitors within their country
- contribute inspiration to a sustainable future Europe.
“And because these companies are highly innovative, the jobs they create tend to be high quality and well paid, helping to boost productivity”, the LSEG reasoned.
“This report is more than just a celebration of these extremely successful companies. It continues to demonstrate what we instinctively know to be true – that these companies are the best hope for future European economic growth and job creation.”
Innovator of the Year in 2018 and 2019
The German business magazine brand eins and the online portal for statistics Statista have been showcasing the most innovative companies in Germany since 2016. In 2018, the industry and innovation experts ranked InfectoPharm as Innovator of the Year for the first time – a distinction we received again in the following year.
“The award proves that InfectoPharm is a pioneer when it comes to intelligent products, processes and services.”
Dr. Friedrich Schwandt, Managing Director of Statista
Healthcare profession news
Pharma Trend Deutschland uses opinion polls among physicians to assess the innovative strength and sustainability of pharmaceutical companies. Based on these results, the companies are ranked and three awards are presented every year. In 2016 and 2018, InfectoPharm took first place in all three competitions.
“Golden Tablet” (Goldene Tablette) award from pediatricians and allergologists
This prize has been awarded since 2002. Well in front of other pharmaceutical companies, InfectoPharm has been ranked first by pediatricians from the very beginning. Above all, pediatricians value our
- relevant training services (72 %),
- high-quality products (35 %),
- service to patients (20 %), and
- our broad range of pediatric products (34 %).
In 2016, InfectoPharm also won the “Goldene Tablette” award from allergologists.
“Most Innovative Product” award (Das innovativste Produkt)
This annual prize is granted on the basis of product efficacy, tolerability and additional benefits compared to previous therapy options. In 2011, two of our products took first and second place respectively: InfectoDexaKrupp® and SalbuBronch®. In 2016, 2017 and 2018, Scabioral®, a product for the skin disease scabies, won most innovative product. In 2019, Slenyto® topped Scabioral®, a mini-tablet to be applied by sleeping disorders of children with Autism Spectrum Disorder. Quite a remarkable outcome, since Slenyto® had just been on the German market for four months in the relevant time period.
This award reflects the reputation of InfectoPharm among physicians for providing innovative products that make it significantly easier to administer pharmaceuticals, especially to children.
Best pharmaceutical companies
InfectoPharm received this image award in 2016, and again in 2018. The first place in the category “Germany – large sole proprietor, medium-sized and international companies” is a recognition of the company’s overall impact. Criteria such as service quality, transparency, credibility and ethical conduct are just as much part of the assessment as innovation, management quality and business success. In 2019, we came in second.